ab52968 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab52968 は 18 報の論文で使用されています。

  • Petta S  et al. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease. J Hepatol 64:682-90 (2016). WB, IF, IHC ; Human . PubMed: 26596542
  • Minson KA  et al. The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia. JCI Insight 1:e85630 (2016). WB ; Human . PubMed: 27158668
  • Lee-Sherick AB  et al. Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia. Oncotarget 6:6722-36 (2015). WB ; Human . PubMed: 25762638
  • Xie S  et al. Mer receptor tyrosine kinase is frequently overexpressed in human non-small cell lung cancer, confirming resistance to erlotinib. Oncotarget 6:9206-19 (2015). WB ; Human . PubMed: 25826078
  • Bernsmeier C  et al. Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK. Gastroenterology 148:603-615.e14 (2015). IHC-P ; Human . PubMed: 25479139
  • Roggia MF & Ueta T avß5 Integrin/FAK/PGC-1a Pathway Confers Protective Effects on Retinal Pigment Epithelium. PLoS One 10:e0134870 (2015). WB, Functional Studies ; Human . PubMed: 26244551
  • Cummings CT  et al. Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status. Mol Cancer Ther 14:2014-22 (2015). WB . PubMed: 26162689
  • Pierce AM & Keating AK TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system. Brain Res 1542:206-20 (2014). WB . PubMed: 24184575
  • Ranganathan V  et al. Expansion of the CRISPR-Cas9 genome targeting space through the use of H1 promoter-expressed guide RNAs. Nat Commun 5:4516 (2014). PubMed: 25105359
  • Brandao LN  et al. Inhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemia. Blood Cancer J 3:e101 (2013). WB ; Human . PubMed: 23353780
  • Lee-Sherick AB  et al. Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia. Oncogene N/A:N/A (2013). WB ; Human . PubMed: 23474756
  • Schlegel J  et al. MERTK receptor tyrosine kinase is a therapeutic target in melanoma. J Clin Invest 123:2257-67 (2013). IHC-P ; Human . PubMed: 23585477
  • Wang Y  et al. Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme. Oncogene : (2012). PubMed: 22469987
  • Migdall-Wilson J  et al. Prolonged exposure to a Mer ligand in leukemia: Gas6 favors expression of a partial Mer glycoform and reveals a novel role for Mer in the nucleus. PLoS One 7:e31635 (2012). WB, ICC/IF ; Human . PubMed: 22363695
  • Deng WT  et al. Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats. Invest Ophthalmol Vis Sci 53:1895-904 (2012). PubMed: 22408006
  • Garbin U  et al. Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids? Cardiovasc Res : (2012). IHC ; Human . PubMed: 22997156
  • McGill TJ  et al. Transplantation of human central nervous system stem cells - neuroprotection in retinal degeneration. Eur J Neurosci 35:468-77 (2012). PubMed: 22277045
  • Carr AJ  et al. Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol Vis 15:283-95 (2009). WB, Blocking . PubMed: 19204785